探索β-catenin突变型肝细胞腺瘤的影像学特征:系统综述与Meta分析
该系统综述与Meta分析检索328篇文献,纳入13篇、共94个β-catenin突变型肝细胞腺瘤(B-HCA),平均大小6.46 cm,坏死占32.65%;MRI T1WI等信号47%、低信号36%,T2WI等-轻度高信号60%、高信号38%,动脉期高强化87%,中央瘢痕47.05%;47.72%的B-HCA演变为恶性病变。
要点
- B-HCA动脉期高强化占87%,T2WI等-轻度高信号占60%,可类似局灶性结节性增生。
- 中央瘢痕见于47.05%的B-HCA,坏死占32.65%,需注意与FNH等鉴别。
- 47.72%的B-HCA演变为恶性病变,管理策略应与肝细胞癌一致。
核心结论
- B-HCA的影像表现可能类似局灶性结节性增生,使诊断复杂化。
- 鉴于恶性转化风险高,B-HCA的管理策略应与肝细胞癌一致。
- 强调全面MRI评估与临床背景在诊断B-HCA中的重要性,主张谨慎解读影像学表现以指导活检决策。
研究设计与样本
- 系统综述与Meta分析,检索数据库共获得328篇文章,13篇符合纳入标准。
- 分析纳入94个B-HCA,平均大小6.46 cm。
关键影像表现/征象
- T1加权MRI显示等信号占47%、低信号占36%。
- T2加权MRI显示等-轻度高信号占60%、高信号占38%。
- 动脉期87%的病灶表现为高强化。
- 中央瘢痕见于47.05%的病例,环礁征和病灶内出血较少见。
- 坏死患病率为32.65%。
诊断标准与关键数值
- MRI T1WI等信号47%、低信号36%;T2WI等-轻度高信号60%、高信号38%;动脉期高强化87%;中央瘢痕47.05%;坏死32.65%;恶性转化47.72%。
临床应用与阅片要点
- B-HCA的影像特征可能类似局灶性结节性增生,诊断时需结合临床背景全面评估MRI。
- 作者主张谨慎解读影像学表现,以指导潜在的活检决策。
- 鉴于恶性转化风险高,作者认为B-HCA的管理策略应与肝细胞癌一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatocellular adenomas are rare benign liver tumors primarily affecting young women, particularly those using oral contraceptives. This systematic review and meta-analysis aimed to evaluate the radiologic features of beta-catenin mutated HCAs with a focus on enhancing diagnostic accuracy and informing management strategies. A comprehensive search of databases yielded 328 articles, with 13 meeting inclusion criteria. The analysis included 94 B-HCAs, revealing a mean size of 6.46 cm and a notable prevalence of necrosis (32.65%). Imaging characteristics demonstrated that T1-weighted MRI showed isointensity in 47% and hypointensity in 36% of lesions, while T2-weighted MRI indicated iso-mild hyperintensity in 60% and hyperintensity in 38%. In the arterial phase, 87% of lesions exhibited hyperenhancement. The presence of a central scar was noted in 47.05% of cases, while the atoll sign and intralesional hemorrhage were less common. The study found a significant tendency for malignant transformation, with 47.72% of B-HCAs evolving into malignant lesions. The findings suggest that B-HCAs may present features similar to focal nodular hyperplasia, complicating diagnosis. Given the high risk of malignancy, management strategies for B-HCAs should align with those for hepatocellular carcinoma. This review underscores the importance of comprehensive MRI evaluation and clinical context in diagnosing B-HCAs, advocating for cautious interpretation of imaging findings to guide potential biopsy decisions.
引用
- Moradi Z, Khalaj F, Soltani S, et al. Exploring radiological characteristics in beta-catenin-mutated hepatocellular adenoma: a systematic review and meta-analysis. Abdom Radiol (NY). 2025. PMID: 40719924. doi:10.1007/s00261-025-05106-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。